Cost-effectiveness analyses of colorectal cancer screening: A systematic review for the US preventive services task force

被引:452
作者
Pignone, M [1 ]
Saha, S
Hoerger, T
Mandelblatt, J
机构
[1] Univ N Carolina, Chapel Hill & Res Triangle Inst, Evidence Based Practice Ctr, Chapel Hill, NC 27514 USA
[2] Res Triangle Inst, Res Triangle Pk, NC 27709 USA
[3] Oregon Hlth & Sci Univ, Evidence Based Practice Ctr, Portland, OR USA
[4] Georgetown Univ, Ctr Med, Washington, DC USA
关键词
D O I
10.7326/0003-4819-137-2-200207160-00007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To perform a systematic review of the cost-effectiveness of colorectal cancer screening for the U.S. Preventive Services Task Force. Data Sources: MEDLINE and the British National Health Service Economic Evaluation Database, January 1993 through September 2001. Study Selection: original economic evaluations of colorectal cancer screening in average-risk patients were reviewed. The authors sought studies addressing the incremental cost-effectiveness of different screening strategies compared with no screening, of different screening strategies compared with one another, and of different ages of screening initiation and cessation. Two investigators independently reviewed each abstract, and potentially eligible articles were retrieved. A four-member working group reached consensus regarding final inclusion or exclusion of articles. Data Extraction: One reviewer extracted data into evidence tables. The results were checked by other members and discrepancies resolved by consensus. Data Synthesis: Among 180 potential articles identified, 7 were retained in the final analysis. Compared with no screening, cost-effectiveness ratios for screening with any of the commonly considered methods were generally between $10 000 and $25 000 per life-year saved. No one strategy was consistently found to be the most effective or to have the best incremental cost-effectiveness ratio. Currently available models provided insufficient evidence to determine optimal starting and stopping ages for screening. Conclusions: screening for colorectal cancer appears cost-effective compared with no screening, but a single optimal strategy cannot be determined from the currently available data. Additional data regarding adherence with screening over time, complication rates in real-world settings, and colorectal cancer biology are needed. Additional analyses are necessary to determine optimal ages of initiation and cessation.
引用
收藏
页码:96 / 104
页数:9
相关论文
共 25 条
  • [1] *AM CANC SOC, 2002, CANC FACTS FIG
  • [2] BROWN ML, 1999, PRIM CARE CANC, V19, P15
  • [3] SCREENING FOR COLORECTAL-CANCER
    EDDY, DM
    [J]. ANNALS OF INTERNAL MEDICINE, 1990, 113 (05) : 373 - 384
  • [4] Cost-effectiveness of screening for colorectal cancer in the general population
    Frazier, AL
    Colditz, GA
    Fuchs, CS
    Kuntz, KM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (15): : 1954 - 1961
  • [5] Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer
    Glick, S
    Wagner, JL
    Johnson, CD
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 1998, 170 (03) : 629 - 636
  • [6] Hankey, 1973, SEER CANC STAT REV
  • [7] A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults
    Khandker, RK
    Dulski, JD
    Kilpatrick, JB
    Ellis, RP
    Mitchell, JB
    Baine, WB
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2000, 16 (03) : 799 - 810
  • [8] Use of colonoscopy to screen asymptomatic adults for colorectal cancer
    Lieberman, DA
    Weiss, DG
    Bond, JH
    Ahnen, DJ
    Garewal, H
    Chejfec, G
    Harford, WV
    Provenzale, D
    Sontag, S
    Schnell, T
    Campbell, DR
    Durbin, TE
    Nelson, DB
    Ewing, SL
    Triadafilopoulos, G
    Ramirez, FC
    Lee, JG
    Collins, JF
    Fennerty, B
    Johnston, TK
    Corless, CT
    McQuaid, KR
    Sampliner, RE
    Morales, TG
    Fass, R
    Smith, R
    Maheshwari, Y
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (03) : 162 - 168
  • [9] COST-EFFECTIVENESS MODEL FOR COLON-CANCER SCREENING
    LIEBERMAN, DA
    [J]. GASTROENTEROLOGY, 1995, 109 (06) : 1781 - 1790
  • [10] One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon
    Lieberman, DA
    Weiss, DG
    Harford, WV
    Ahnen, DJ
    Provenzale, D
    Sontag, SJ
    Schnell, TG
    Chejfec, G
    Campbell, DR
    Durbin, TE
    Bond, JH
    Nelson, DB
    Ewing, SL
    Triadafilopoulos, G
    Ramirez, FC
    Lee, JG
    Collins, JF
    Fennerty, B
    Johnston, TK
    Corless, CL
    McQuaid, KR
    Garewal, H
    Sampliner, RE
    Morales, TG
    Fass, R
    Smith, RE
    Maheshwari, Y
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (08) : 555 - 560